We are live on ! Find out more
IVM

InterWest Venture Management Portfolio holdings

AUM $20.6M
1-Year Est. Return 48.5%
This Fund
S&P 500
This Quarter Est. Return
-12.23%
1 Year Est. Return
+48.5%
3 Year Est. Return
-57.65%
5 Year Est. Return
-76.52%
10 Year Est. Return
–
AUM
$32.4M
AUM Growth
-$21.3M
Cap. Flow
-$17.3M
Cap. Flow %
-53.27%
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
GKOS icon
Glaukos
GKOS
+$17.3M

Sector Composition

Rank Sector Weight
1 Healthcare 89.12%
2 Consumer Discretionary 10.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PMVP icon
1
PMV Pharmaceuticals
PMVP
$60.3M
$19.2M 59.24%
1,614,911
– –
EIGR
2
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$4.22M 13.02%
18,700
– –
SERA icon
3
Sera Prognostics
SERA
$79.5M
$3.87M 11.92%
2,416,241
– –
REAL icon
4
The RealReal
REAL
$1.37B
$3.53M 10.88%
2,354,080
– –
GKOS icon
5
Glaukos
GKOS
$8.78B
$870K 2.68%
16,347
-334,897
-95% -$17.3M
AGTC
6
DELISTED
Applied Genetic Technologies Corporation
AGTC
$381K 1.17%
1,404,515
– –
VERO
7
DELISTED
Venus Concept
VERO
$290K 0.89%
3,992
– –
DARE icon
8
Dare Bioscience
DARE
$19.3M
$62K 0.19%
5,172
– –

Similar funds

RCP
Rho Capital Partners New York $20.4M AUM
LUGPI
Lightspeed Ultimate General Partner IX Menlo Park, California $20.3M AUM 4.78% 1-Year Est. Return
SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
DOS
David O. Sacks $19.8M AUM 4.02% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
CVSCT
C.V. Starr & Co Trust New York $19.4M AUM 28.57% 1-Year Est. Return
VNB
Virginia National Bank Charlottesville, Virginia $21.9M AUM 12.04% 1-Year Est. Return
BEP
Brookside Equity Partners Stamford, Connecticut $22.5M AUM 62.43% 1-Year Est. Return

InterWest Venture Management's Q3 2022 Portfolio in Review

As of Q3 2022, InterWest Venture Management held 8 positions worth $32.4M, down 40% from $53.8M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

InterWest Venture Management withdrew a net $17.3M in Q3 2022, reducing 1 holding. Its largest reduction was Glaukos, cutting an estimated $17.3M.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 89% a quarter earlier, followed by Consumer Discretionary.

  • InterWest Venture Management's biggest Q3 2022 reduction was Glaukos, cutting an estimated $17.3M.
  • InterWest Venture Management's ten largest holdings make up 100% of its $32.4M portfolio in Q3 2022.
  • InterWest Venture Management opened 0 new positions and closed 0 in Q3 2022.
  • InterWest Venture Management's portfolio value fell 40% quarter-over-quarter to $32.4M.

Based on InterWest Venture Management's 13F filing for Q3 2022, filed 25 Oct 2022.